Tue, Jan 26, 2021
The 52 Week Low is $2.52 set on Fri, Apr 3, 2020.
The 52 Week High is $19.07 set on Mon, Jan 25, 2021.
The All-Time High is $37.50 set on Wed, Jul 29, 2015.
Earnings Per Share
Price To Earnings Ratio
Dividend Payment Date
NantKwest Inc trades on the NASDAQ. NK's market cap is 1.9 Billion.
NantKwest Inc is a United States-based firm functioning in the healthcare sector. It is focused on providing immunotherapeutic agents, especially natural killer cells to treat cancer, infectious and inflammatory diseases. Natural Killer (NK) cells are ancient cells in the human body designed to recognize and detect cells under stress or infected. The company's drug candidates such as activated NK cells, high-affinity NKs and target activated NK's address virally-induced cancers, viral, fungal and bacterial infections as well as critical diseases such as Ebola. Its pipeline product includes taNK, haNK, and aNK. Most of NatWest's sales are concentrated in the United States region although it has a reasonable market in Europe and other Non-U.S. territories.